Hikma Pharmaceuticals (HIK) News Today GBX 2,130 -18.00 (-0.84%) As of 05/29/2025 11:51 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock HIK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Hikma Pharmaceuticals advances Wednesday, outperforms marketMay 28 at 6:50 PM | marketwatch.comGrowth is what results from strategy. Luckily, this firm has a planMay 27 at 5:37 AM | finance.yahoo.comReshaped Combogesic deal sets 'pleased' AFT Pharma up to answer US demandMay 26, 2025 | msn.comHikma Pharmaceuticals (LON:HIK) Share Price Passes Above 200-Day Moving Average - Should You Sell?Hikma Pharmaceuticals (LON:HIK) Stock Price Passes Above 200-Day Moving Average - Should You Sell?May 26, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Trading Up 7.4% - Still a Buy?Hikma Pharmaceuticals (LON:HIK) Stock Price Up 7.4% - Still a Buy?May 18, 2025 | marketbeat.comFTSE 100 battles higher as defensive stocks sought, Aviva and Hikma make splashMay 16, 2025 | uk.investing.comU.K. stocks rise for first time in two daysMay 15, 2025 | marketwatch.comHikma shares climb on new outlook, targets USD5 billion sales by 2030May 15, 2025 | lse.co.ukEuropean stocks rise as US and China agree to slash tariffsMay 13, 2025 | msn.comS&P upgrades Hikma Pharmaceuticals PLC, senior notes to ‘BBB’May 13, 2025 | msn.comHikma Pharmaceuticals gets ’BBB’ rating upgrade from S&P on strong momentumMay 8, 2025 | investing.comHikma Pharma to pay $50 million to settle narcolepsy drug antitrust caseMay 8, 2025 | msn.comHealthcare and consumer gains propel UK shares higherApril 28, 2025 | msn.comHikma Pharmaceuticals advances Monday, outperforms marketApril 28, 2025 | marketwatch.comHikma shares edge up on steady guidanceApril 24, 2025 | uk.investing.comHikma reiterates full year guidance following good start to the yearApril 24, 2025 | msn.comIs this FTSE 100 share a screaming buy to consider after recent falls?April 22, 2025 | msn.comInsider Selling: Hikma Pharmaceuticals PLC (LON:HIK) Insider Sells 2,777 Shares of StockHikma Pharmaceuticals PLC (LON:HIK - Get Free Report) insider Victoria Hull sold 2,777 shares of the stock in a transaction on Tuesday, April 8th. The stock was sold at an average price of GBX 1,800 ($22.91), for a total value of £49,986 ($63,627.80).April 10, 2025 | marketbeat.comLONDON BROKER RATINGS: Jefferies raises Hikma Pharmaceutical to 'buy'April 10, 2025 | lse.co.ukHikma signs licensing agreement to bring innovative oncology treatment to MENAApril 9, 2025 | msn.comHikma Pharmaceuticals slips Wednesday, underperforms marketApril 9, 2025 | marketwatch.comFTSE 100 Live 09 April: Oil and pharma stocks retreat as heavy selling resumesApril 9, 2025 | msn.comHikma signs exclusive licensing agreement to bring innovative oncology treatment to MENAApril 9, 2025 | msn.comHikma Pharmaceuticals PLC (LON:HIK) Insider Sells £49,986 in StockApril 9, 2025 | insidertrades.comAn Idaho warden acquired lethal injection drugs from an undisclosed supplier on a rural roadApril 5, 2025 | msn.comThe top British companies to see a share price drop on the back of Trump's tariffsApril 4, 2025 | msn.comFTSE 100 Live 02 April: Tariff fears hit blue-chip stocks, Raspberry Pi shares surgeApril 2, 2025 | msn.comFTSE 100 Live 02 April: Tariff fears hit blue-chip stocks , Raspberry Pi shares surgeApril 2, 2025 | msn.comHikma Pharmaceuticals (LON:HIK) Share Price Passes Above 200 Day Moving Average - Should You Sell?Hikma Pharmaceuticals (LON:HIK) Stock Passes Above 200 Day Moving Average - What's Next?March 26, 2025 | marketbeat.comHikma Pharmaceuticals announces Health Canada approval of KLOXXADO nasal sprayMarch 20, 2025 | markets.businessinsider.comHikma Pharmaceuticals PLC (LON:HIK) Increases Dividend to $0.48 Per ShareHikma Pharmaceuticals PLC (LON:HIK) announced a dividend on Wednesday, February 26th. Stockholders of record on Thursday, March 20th will be given a dividend of $0.48 per share on Thursday, May 1st. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, March 20th. This is a 50.0% increase from Hikma Pharmaceuticals's previous dividend of $0.32. The official announcement can be accessed at this link.March 19, 2025 | marketbeat.comShould Income Investors Look At Hikma Pharmaceuticals PLC (LON:HIK) Before Its Ex-Dividend?March 16, 2025 | finance.yahoo.comHikma Pharmaceuticals slips Thursday, underperforms marketMarch 13, 2025 | marketwatch.comHikma Pharmaceuticals (LON:HIK) Earns "Buy" Rating from Berenberg BankBerenberg Bank reiterated a "buy" rating and set a GBX 2,560 ($33.14) price objective on shares of Hikma Pharmaceuticals in a research report on Monday.March 13, 2025 | marketbeat.comHikma races to launch generic versions of blockbuster obesity drugsMarch 9, 2025 | ft.comHikma Pharmaceuticals' (HIK) "Overweight" Rating Reaffirmed at JPMorgan Chase & Co.JPMorgan Chase & Co. reissued an "overweight" rating on shares of Hikma Pharmaceuticals in a report on Friday.March 7, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Stock Crosses Above 200 Day Moving Average - What's Next?Hikma Pharmaceuticals (LON:HIK) Share Price Crosses Above 200-Day Moving Average - Time to Sell?March 1, 2025 | marketbeat.comRBC Capital Keeps Their Buy Rating on Hikma Pharmaceuticals (HIK)February 27, 2025 | markets.businessinsider.comHikma Pharmaceuticals (HIK) Receives a Buy from J.P. MorganFebruary 27, 2025 | markets.businessinsider.comHikma Pharmaceuticals reports 'strong' 2024 results with 9% revenue growthFebruary 26, 2025 | msn.comHikma Pharmaceuticals slides Wednesday, underperforms marketFebruary 26, 2025 | marketwatch.comHikma shares fall as margins disappoint, despite revenue beatFebruary 26, 2025 | investing.comHikma Pharmaceuticals Reports Strong 2024 Results with 9% Revenue GrowthFebruary 26, 2025 | msn.comHikma’s profit jumps as demand for generic medicines boomsFebruary 26, 2025 | msn.comHikma Pharmaceuticals' revenue grows nine per cent to £2.47bn as profit boomsFebruary 26, 2025 | msn.comHikma Pharmaceuticals advances Friday, outperforms marketFebruary 21, 2025 | marketwatch.comHikma Pharmaceuticals (LON:HIK) Shares Pass Above 200-Day Moving Average - Time to Sell?Hikma Pharmaceuticals (LON:HIK) Shares Cross Above 200-Day Moving Average - Should You Sell?February 20, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Sets New 52-Week High - Time to Buy?Hikma Pharmaceuticals (LON:HIK) Reaches New 12-Month High - Time to Buy?February 12, 2025 | marketbeat.comInvesting in Hikma Pharmaceuticals (LON:HIK) five years ago would have delivered you a 38% gainFebruary 11, 2025 | finance.yahoo.comHikma Pharmaceuticals (LON:HIK) Hits New 1-Year High - Here's What HappenedHikma Pharmaceuticals (LON:HIK) Reaches New 12-Month High - Still a Buy?February 6, 2025 | marketbeat.com Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HIK and its competitors with MarketBeat's FREE daily newsletter. Email Address HIK Media Mentions By Week HIK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIK News Sentiment▼0.490.87▲Average Medical News Sentiment HIK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIK Articles This Week▼42▲HIK Articles Average Week Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HIK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HUTCHMED News Indivior News Allergy Therapeutics News Alliance Pharma News Animalcare Group News Venture Life Group News ECO Animal Health Group News Shield Therapeutics News Chill Brands Group News Celadon Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HIK) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersBuffett’s Next Move Could Shock Wall StreetIn just a few weeks, a move decades in the making could be revealed — and when it is, it could ignite the next...Golden Portfolio | SponsoredElon Musk’s Frightening Warning Forces Trump’s HandElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HIK Stock Free HIK Stock Alerts